FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985079969> ?p ?o ?g. }

• W1985079969 endingPage "165" @default.
• W1985079969 startingPage "150" @default.
• W1985079969 abstract "The issue of optimal duration of oral anticoagulant therapy after a first episode of venous thromboembolism is still unresolved. However, recent data suggest that short (6 weeks to 3 months), intermediate (3- 6 months) or indefinite-term anticoagulant therapy should be adopted on the basis of the classification of patients into low-, intermediate- and high-recurrence-risk groups, respectively. Oral anticoagulants have been shown to effectively prevent cardioembolic stroke in nonvalvular atrial fibrillation. Recent data seem to suggest that their safety can be ameliorated with adequate risk stratification on the basis of clinical and echocardiographic features. After unstable angina and non-Q-wave myocardial infarction, oral anticoagulant therapy (INR range 2-3) combined with aspirin has been shown to be advantageous over aspirin alone, although at the cost of a slight increase in bleeding. Bleeding complications are major drawbacks of oral anticoagulant therapy thus limiting their generalized adoption in recognized indications. To sharply reduce the bleeding risk and need of laboratory control, the low- or fixed-dose oral anticoagulant approach has been evaluated. In primary prevention and in low or low-to-moderate thrombotic risk, minidose warfarin treatment has been shown to be advantageous. In secondary prevention, and in patients at high risk for recurrent venous or arterial thrombotic events, standard range (INR 2-3) or higher level of anticoagulation is needed." @default.
• W1985079969 created "2016-06-24" @default.
• W1985079969 creator A5008150148 @default.
• W1985079969 creator A5043870217 @default.
• W1985079969 creator A5055517858 @default.
• W1985079969 date "1999-01-01" @default.
• W1985079969 modified "2023-09-27" @default.
• W1985079969 title "Oral Anticoagulant Therapy: Efficacy, Safety and the Low-Dose Controversy" @default.
• W1985079969 cites W137344628 @default.
• W1985079969 cites W1522694313 @default.
• W1985079969 cites W177354328 @default.
• W1985079969 cites W1819664549 @default.
• W1985079969 cites W1901279264 @default.
• W1985079969 cites W1968634159 @default.
• W1985079969 cites W1978283806 @default.
• W1985079969 cites W1985595174 @default.
• W1985079969 cites W1987034302 @default.
• W1985079969 cites W1989192399 @default.
• W1985079969 cites W1990014885 @default.
• W1985079969 cites W1990912672 @default.
• W1985079969 cites W1992857447 @default.
• W1985079969 cites W1992997314 @default.
• W1985079969 cites W199357843 @default.
• W1985079969 cites W1994894525 @default.
• W1985079969 cites W2001411232 @default.
• W1985079969 cites W2007303097 @default.
• W1985079969 cites W2007650238 @default.
• W1985079969 cites W2012111597 @default.
• W1985079969 cites W2012328700 @default.
• W1985079969 cites W2025985576 @default.
• W1985079969 cites W2026589095 @default.
• W1985079969 cites W2029045834 @default.
• W1985079969 cites W2040251457 @default.
• W1985079969 cites W2040452288 @default.
• W1985079969 cites W204140586 @default.
• W1985079969 cites W2044889252 @default.
• W1985079969 cites W2064836413 @default.
• W1985079969 cites W2065011730 @default.
• W1985079969 cites W2066076015 @default.
• W1985079969 cites W2066490209 @default.
• W1985079969 cites W2071233061 @default.
• W1985079969 cites W2072113308 @default.
• W1985079969 cites W2074616500 @default.
• W1985079969 cites W2084124265 @default.
• W1985079969 cites W2100184560 @default.
• W1985079969 cites W2104674675 @default.
• W1985079969 cites W2110392825 @default.
• W1985079969 cites W2110415473 @default.
• W1985079969 cites W2113384129 @default.
• W1985079969 cites W2118654837 @default.
• W1985079969 cites W2129574541 @default.
• W1985079969 cites W2136842266 @default.
• W1985079969 cites W2143681591 @default.
• W1985079969 cites W2145537216 @default.
• W1985079969 cites W2150666115 @default.
• W1985079969 cites W2160781070 @default.
• W1985079969 cites W2172227095 @default.
• W1985079969 cites W2188507800 @default.
• W1985079969 cites W2283740320 @default.
• W1985079969 cites W2285109455 @default.
• W1985079969 cites W2313752590 @default.
• W1985079969 cites W2326914415 @default.
• W1985079969 cites W2327974959 @default.
• W1985079969 cites W2332640098 @default.
• W1985079969 cites W2337130116 @default.
• W1985079969 cites W2338244864 @default.
• W1985079969 cites W2399665981 @default.
• W1985079969 cites W2499224120 @default.
• W1985079969 cites W42860337 @default.
• W1985079969 cites W44202489 @default.
• W1985079969 cites W68303585 @default.
• W1985079969 cites W85067171 @default.
• W1985079969 cites W94861547 @default.
• W1985079969 doi "https://doi.org/10.1159/000022495" @default.
• W1985079969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10629394" @default.
• W1985079969 hasPublicationYear "1999" @default.
• W1985079969 type Work @default.
• W1985079969 sameAs 1985079969 @default.
• W1985079969 citedByCount "5" @default.
• W1985079969 crossrefType "journal-article" @default.
• W1985079969 hasAuthorship W1985079969A5008150148 @default.
• W1985079969 hasAuthorship W1985079969A5043870217 @default.
• W1985079969 hasAuthorship W1985079969A5055517858 @default.
• W1985079969 hasConcept C126322002 @default.
• W1985079969 hasConcept C127413603 @default.
• W1985079969 hasConcept C141071460 @default.
• W1985079969 hasConcept C164705383 @default.
• W1985079969 hasConcept C177713679 @default.
• W1985079969 hasConcept C2776301958 @default.
• W1985079969 hasConcept C2777628954 @default.
• W1985079969 hasConcept C2777785093 @default.
• W1985079969 hasConcept C2778205648 @default.
• W1985079969 hasConcept C2779161974 @default.
• W1985079969 hasConcept C2780645631 @default.
• W1985079969 hasConcept C2992750412 @default.
• W1985079969 hasConcept C500558357 @default.
• W1985079969 hasConcept C71924100 @default.
• W1985079969 hasConcept C78519656 @default.

• next